Newly released figures show the number of drug reps taking the ABPI exam for new reps dropped 50% in 2006; clear proof that the size and composition of UK pharma's salesforces are changing fast. The ABPI has informed Pharmafocus that applicants for the exam, which new reps must take within the first two years in the job, fell to just 600 last year.
The industry body says the numbers have been in decline for four years, but that 2006 saw the greatest fall. The statistics reveal more starkly than ever before the changing nature of the UK industry, which is following a global trend away from large, primary-care focused salesforces to smaller, specialist teams.
The industry body says the numbers have been in decline for four years, but that 2006 saw the greatest fall. The statistics reveal more starkly than ever before the changing nature of the UK industry, which is following a global trend away from large, primary-care focused salesforces to smaller, specialist teams.
No comments:
Post a Comment